PERMIXON caps 160 mg 30 pce

7680527590135 CH-52759 G04CX02 05.98.0.
PERMIXON caps 160 mg 30 pce
PERMIXON caps 160 mg 30 pce
PERMIXON caps 160 mg 30 pce
1 / 3
google

Details

Product number
5275901
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
sabalis serrulatae extractum (Serenoa repens (W.Bartram) Small, fructus) 160 mg, DER: 7-11:1, Auszugsmittel Hexan, macrogolum 10'000, Kapselhülle: gelatina, E 171, E 132, E 172 (flavum), pro capsula.

Articles (1)

Permixon, Kapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/03/2016
Patient information leaflet
Français
17/03/2016
Patient information leaflet
Italien
17/03/2016

Detailed composition

Substance Quantity Type Category
(N/A)
160.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Pierre Fabre Pharma SA

4052 Basel

Authorization information

Swissmedic authorization number
52759
Drug name
Permixon, Kapseln
Galenic form
KAHA
ATC Code
G04CX02
Authorization status
Z
Dispensation category
D
First authorization
21/04/1995
Authorization expiration date
31/12/9999
IT number
05.98.0.
Domain
Human medicine
Field of application
Bei beginnender Prostatavergrösserung

Packaging details

Description (FR)
PERMIXON caps 160 mg 30 pce
Description (DE)
PERMIXON Kaps 160 mg 30 Stk
Market launch
21/04/1995
Narcotic (BTM)
No

Other packaging sizes

PERMIXON caps 160 mg 60 pce
60 KAP
View